Last Price
0.088
Today's Change
-0.007 (7.36%)
Day's Change
0.085 - 0.095
Trading Volume
27,667,351
Profile
NFX
Currency: GBp GBp
Sector: Healthcare - Healthcare Healthcare - Healthcare
Description
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.
Address
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Latest Videos
![[New IPO] PMCK Berhad, a healthcare services provider, plans to list on the Ace Market!](https://mqac.i3investor.com/img/video_thumbnail/1180/Thumbnail__(7).png)
![[New IPO] ASM Automation Group Berhad, a F&B automation solutions provider, plans to list on the Ace Market!](https://mqac.i3investor.com/img/video_thumbnail/1177/Thumbnail__(6).png)
![[New IPO] Pan Merchant Berhad, plans to list on the Ace Market!](https://mqac.i3investor.com/img/video_thumbnail/1174/Thumbnail__(5).png)
Apps
Top Articles
1
Stumbling and Mumbling
2
Stumbling and Mumbling
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
